Produtos Farmacêuticos da Cadeia de Frio: 2025 Tendências & Práticas recomendadas
Atualizado em novembro 20, 2025 Cold chain pharmaceuticals refer to temperature controlled drugs and biologics that must be kept within strict ranges during manufacture, armazenamento e distribuição. The global cold chain industry is projected to reach US$393–453 billion in 2025 and scale to US$1.63 trillion by 2035. This growth is powered by surging demand for biologics, gene therapies and weight loss drugs that require refrigerated or ultra cold storage. In this article you’ll learn how to prepare for this evolving market, why technology and sustainability matter, and what practical steps you can take now. Motivadores de demanda: how biologics, cell and gene therapies and changing disease patterns increase cold chain requirements. Inovações tecnológicas: Sensores de IoT, Robótica, AI and smart packaging that enable real time visibility and reduce waste. Pressões regulatórias e de sustentabilidade: why new rules and carbon reduction goals are reshaping temperature controlled logistics. Orientação prática: actions you can take to improve compliance, reduce risk and build resilience, including a self assessment tool. What Drives the Surging Demand for Cold Chain Pharmaceuticals? Rising global demand for temperature sensitive...
